Search

Search Constraints

You searched for: Author/Creator Komajda, Michel

Search Results

1. A novel genetic variant in the transcription factor Islet‐1 exerts gain of function on myocyte enhancer factor 2C promoter activity. (March 2013)

2. A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction. (10th October 2014)

4. Asymptomatic left ventricular dysfunction in patients with type 2 diabetes free of cardiovascular disease and its relationship with clinical characteristics: The DIACAR cohort study. Issue 2 (24th November 2020)

5. Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m. (8th October 2019)

6. Brain natriuretic peptide usefulness in very elderly dyspnoeic patients: the BED study. (26th December 2016)

7. Changes in N‐terminal pro‐B‐type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I‐Preserve study. (29th April 2015)

8. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. (6th August 2015)

9. Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post‐hoc analysis of SHIFT. (22nd May 2016)

10. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction). Issue 8 (21st February 2017)